EUROIMMUN Logo
Find
X

What are you looking for?

Filter for products in our complete portfolio

Product finder

Worldwide
X
EUROIMMUN worldwide

This website provides an overview of the business activities and products of EUROIMMUN AG worldwide. Not all products are registered and approved in all countries or regions. Please contact your country representative for product availability and information

EUROIMMUN branches

Choose your country

Europe

North America

South & Central America

Asia

Middle East & Africa

EUROIMMUN Logo

New automation technologies at the vanguard of IFA diagnostics – An interview with EUROIMMUN

Indirect immunofluorescence assays (IFA) count among the fundamental screening methods for the determination of antibodies, for example in autoimmune or infectious diseases. The global demand for IFA ...

Automated allergy diagnostics from alder to zucchini

Over 30% of people in Germany suffer from an allergy. Whether it’s a runny nose, itchy skin or breathing difficulties – many allergy sufferers only notice minor symptoms at first, but for some they ...

Increasing spread of infectious diseases due to climate change

Experts worldwide have identified climate change as the greatest health challenge of the 21st century. There is growing evidence that climatic changes also favour the emergence, recurrence and ...

EUROIMMUN declares IVDR compliance for risk class A products

Press release

EUROIMMUN, a PerkinElmer, Inc. company, announced today that all laboratory diagnostics in its portfolio have been brought into compliance with the requirements for risk class A ...

Free public antibody testing in Böblingen: EUROIMMUN provides tests for pilot project in Southern Germany

Since 23 February 2022, residents of the district of Böblingen can receive one of 4000 free COVID-19 antibody tests offered by pharmacist Dr Björn Schittenhelm. By determining their antibody titers, ...

Christmas donations for charitable projects

Traditionally, Christmas is the time to reflect on what you have achieved and to turn your attention to those who are less well off.

New guideline recognises anti-PLA2R as a significant biomarker for membranous nephropathy

In October 2021, the organisation KDIGO (Kidney Disease: Improving Clinical Outcomes) published an updated version of the clinical guideline for the management of patients with glomerulonephritis. ...

T cells: Important building blocks of immune protection against SARS-CoV-2

It is becoming increasingly clear that not only antibodies against SARS-CoV-2 play a role in building immunity against the coronavirus. T cells, as part of the cellular immune response, also have ...

The flu season is getting started

After a virtually non-existent flu season in 2020/2021 and with the revival of public life and the relaxation of social distancing measures, there is increasing concern that a large flu wave could ...

New partnership: IDS and EUROIMMUN

We are delighted to welcome Immunodiagnostic Systems Holding (IDS) as the newest member of the PerkinElmer family. The acquisition of the British diagnostics company was officially closed in July ...

Page 4 of 7.

Back to top